News about Global Pharma

Senores Pharmaceuticals Acquires ANDA for Topiramate Tablets from Wockhardt

Senores Pharmaceuticals Ltd., via its US subsidiary, has acquired the USFDA-approved ANDA for Topiramate tablets from Wockhardt Ltd., marking a strategic expansion into the USD 111 million US epilepsy and migraine drug market.

Global Pharma | 06/05/2025 | By Manvi |  549

Human Longevity Adds Avantect Test to Boost Early Pancreatic Cancer Detection

This groundbreaking DNA-based blood test is designed to detect early-stage pancreatic cancer. When integrated with HLI's proprietary whole genome sequencing platform and cutting-edge MRI imaging, it offers one of the most advanced early cancer detection strategies available today.

Global Pharma | 06/05/2025 | By Manvi |  166

FDA Lists Leo Cancer Care's Marie Particle Therapy System as Pending

The Food and Drug Administration Agency (FDA) has updated the regulatory status of Marie®, Leo Cancer Care's upright particle therapy solution, to pending. Marie combines Leo Cancer Care's upright patient positioning system with their upright fan beam CT scanner and can be utilized with any fixed particle beam.

Global Pharma | 06/05/2025 | By Manvi |  360

Biocon Biologics Secures Market Access Coverage for Yesintek in United States

Biocon Biologics has secured market access agreements covering over 100 million lives in the US for Yesintek, its FDA-approved biosimilar to Stelara, marking a major milestone in its US biosimilars launch.

Global Pharma | 05/05/2025 | By Manvi |  222

FDA Accepts Novo Nordisk's NDA for Oral Wegovy for Chronic Weight Management and Heart Risk Reduction

The FDA application is based on results from OASIS 4, a 64-week phase 3 randomized, controlled trial evaluating the efficacy and safety of once-daily oral semaglutide 25 mg versus placebo in 307 adults with obesity (BMI >/= 30 kg/m2) or overweight (BMI >/= 27 kg/m2) with one or more comorbidities. Patients with diabetes were excluded.

Global Pharma | 05/05/2025 | By Manvi |  362

Turn Therapeutics Reaches Milestone in Cold-Storage-Free Vaccine Development

In partnership with the nonprofit International AIDS Vaccine Initiative, Turn Therapeutics has validated a standardized assay and demonstrated 100 percent recovery of vesicular stomatitis virus (VSV) -- a widely used viral backbone in vaccine development -- after both 24 and 72 hours in its proprietary oil-based carrier at room temperature.

Global Pharma | 05/05/2025 | By Manvi |  269

Solvent Direct Launches Cannabis Extraction Safety Program with LSI and CARMA365

Solvent Direct has officially partnered with the Laboratory Safety Institute (LSI) and CARMA365 Insurance to launch a powerful safety and certification program tailored specifically for cannabis extraction professionals.

Global Pharma | 03/05/2025 | By Manvi |  248

USMGC Leases Ohio Facility to Finalize All-American Glove Supply Chain

This critical move marks the final phase in USMGC's mission to build and secure a 100 percent American-made medical and surgical glove supply chain—free from reliance on China or any foreign supplier.

Global Pharma | 03/05/2025 | By Manvi |  407

Alembic Pharmaceuticals Secures USFDA Approval for Ticagrelor Tablets

Alembic Pharmaceuticals has received USFDA final approval for Ticagrelor Tablets, 90 mg, and tentative approval for 60 mg.

Global Pharma | 03/05/2025 | By Manvi |  375

SMS Pharma's Vizag Plant Secures WHO Geneva Prequalification Approval

SMS Pharmaceuticals’ Unit VII facility in Visakhapatnam has received WHO Geneva prequalification, boosting its global regulatory credentials and market access for Anti-Retroviral APIs.

Global Pharma | 03/05/2025 | By Manvi |  465